Home › Compare › MGYOY vs ABBV
MGYOY yields 6.22% · ABBV yields 3.06%● Live data
📍 MGYOY pulled ahead of the other in Year 1
Combined, MGYOY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MGYOY + ABBV for your $10,000?
MOL Magyar Olaj- és Gázipari Nyilvánosan Muködo Részvénytársaság, together with its subsidiaries, operates as an integrated oil and gas company in Hungary and internationally. It operates through five segments: Upstream, Downstream, Consumer Services, Gas Midstream, and Corporate and Other. The company is involved in the refining, transportation, and storage of crude oil; wholesale and retail of crude oil products; geothermal energy production; natural gas transmission; feed water and raw water supply; water transportation; refinery and marketing of oil and petrochemical products; importing and exporting of energetical products; warehousing and oil product storage activities; and exploration and production of crude oil, natural gas, and other gas products. It also engages in the provision of transportation, fleet management, and financial services; marketing agency activities; production and distribution of electricity; production and retail trade of lubricants; and retail and wholesale trade of fuels. In addition, the company provides business, accounting, IT, and company services; construction and engineering, pipeline construction, and leasing activities; repair and maintenance services; investment management services; and real estate management services, as well as manufactures and sells machinery and equipment. Further, it engages in the mineral water production and distribution activities; exploration of hydrocarbon; provision of exploration financing, car sharing, firefighting, tourism, oilfield, and rental services; petrochemicals and consumer retail activities, as well as provision of fire, hospitality, and catering services; and operation of café houses. The company was incorporated in 1991 and is headquartered in Budapest, Hungary.
Full MGYOY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.